secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2025-02-10T23:59:59+00:00
Accession:  0001021771-25-000031
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative Therapies presents at ORS 2025; VP Silva discusses development programs
--------------------------------------------------------------------------------

- Francisco Silva, VP of R&D, presented at Orthopaedic Research Society 2025 Annual Meeting on Feb 8.
- Presentation materials will be posted on company website for 90 days under Scientific Publications.
- No financial or clinical results from the presentation disclosed in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177125000031/0001021771-25-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177125000031/brt8k21025.htm
  HTML page:      https://secwatch.observer/filing/0001021771-25-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer